# Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

> **NCT03495882** · PHASE1,PHASE2 · COMPLETED · sponsor: **Agenus Inc.** · enrollment: 154 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** AGEN1884 + AGEN2034

## Key facts

- **NCT ID:** NCT03495882
- **Lead sponsor:** Agenus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-18
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2023-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03495882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03495882, "Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT03495882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*